Millennium Management’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,548,767
| Closed | -$2.28M | – | 7829 |
|
|
2022
Q2 | $2.28M | Sell |
1,548,767
-4,671,054
| -75% | -$3.43M | ﹤0.01% | 3563 |
|
|
2022
Q1 | $7.15M | Buy |
6,219,821
+4,265,693
| +218% | +$6.95M | ﹤0.01% | 2537 |
|
|
2021
Q4 | $4.88M | Buy |
1,954,128
+1,532,196
| +363% | +$6.02M | ﹤0.01% | 2927 |
|
|
2021
Q3 | $2.16M | Sell |
421,932
-286,928
| -40% | -$1.74M | ﹤0.01% | 3818 |
|
|
2021
Q2 | $5.89M | Buy |
708,860
+117,563
| +20% | +$991K | ﹤0.01% | 2539 |
|
|
2021
Q1 | $5.15M | Buy |
591,297
+426,331
| +258% | +$4.41M | ﹤0.01% | 2538 |
|
|
2020
Q4 | $1.79M | Sell |
164,966
-296,292
| -64% | -$3.66M | ﹤0.01% | 3321 |
|
|
2020
Q3 | $5.5K | Buy |
+461,258
| New | +$6.18M | 0.01% | 1753 |
|
|
2020
Q2 | – | Sell |
-300,646
| Closed | -$4.66M | – | 4782 |
|
|
2020
Q1 | $4.66M | Buy |
300,646
+288,037
| +2,284% | +$6.19M | 0.01% | 1380 |
|
|
2019
Q4 | $310K | Sell |
12,609
-1,162,056
| -99% | -$17.2M | ﹤0.01% | 3651 |
|
|
2019
Q3 | $12.1M | Buy |
1,174,665
+408,574
| +53% | +$5.15M | 0.02% | 1140 |
|
|
2019
Q2 | $9.61M | Sell |
766,091
-1,008,391
| -57% | -$13M | 0.01% | 1293 |
|
|
2019
Q1 | $22M | Buy |
1,774,482
+955,682
| +117% | +$10.7M | 0.03% | 748 |
|
|
2018
Q4 | $5.04M | Buy |
818,800
+687,047
| +521% | +$5.25M | 0.01% | 1585 |
|
|
2018
Q3 | $1.4M | Buy |
131,753
+61,774
| +88% | +$705K | ﹤0.01% | 2674 |
|
|
2018
Q2 | $948K | Sell |
69,979
-781,529
| -92% | -$12.2M | ﹤0.01% | 2872 |
|
|
2018
Q1 | $15.1M | Sell |
851,508
-145,179
| -15% | -$2.45M | 0.02% | 1061 |
|
|
2017
Q4 | $12.5M | Buy |
996,687
+359,547
| +56% | +$5.23M | 0.02% | 1187 |
|
|
2017
Q3 | $12.1M | Buy |
637,140
+97,056
| +18% | +$1.48M | 0.02% | 1121 |
|
|
2017
Q2 | $8.15M | Buy |
540,084
+316,461
| +142% | +$4.78M | 0.01% | 1180 |
|
|
2017
Q1 | $3.83M | Buy |
223,623
+78,801
| +54% | +$1.05M | 0.01% | 1612 |
|
|
2016
Q4 | $1.75M | Sell |
144,822
-129,791
| -47% | -$1.35M | ﹤0.01% | 1950 |
|
|
2016
Q3 | $2.7M | Sell |
274,613
-660,543
| -71% | -$6.03M | ﹤0.01% | 1741 |
|
|
2016
Q2 | $9.58M | Buy |
935,156
+204,492
| +28% | +$2.28M | 0.02% | 877 |
|
|
2016
Q1 | $8.86M | Buy |
+730,664
| New | +$7.39M | 0.02% | 908 |
|
|
2015
Q3 | – | Sell |
-50,000
| Closed | -$1.2M | – | 3832 |
|
|
2015
Q2 | $1.2M | Sell |
50,000
-20,180
| -29% | -$388K | ﹤0.01% | 2190 |
|
|
2015
Q1 | $1.32M | Sell |
70,180
-164,460
| -70% | -$3.4M | ﹤0.01% | 2187 |
|
|
2014
Q4 | $4.43M | Buy |
234,640
+185,909
| +382% | +$4.34M | 0.01% | 1475 |
|
|
2014
Q3 | $1.32M | Sell |
48,731
-15,009
| -24% | -$466K | ﹤0.01% | 2127 |
|
|
2014
Q2 | $1.98M | Buy |
63,740
+52,479
| +466% | +$1.24M | 0.01% | 1786 |
|
|
2014
Q1 | $256K | Buy |
+11,261
| New | +$341K | ﹤0.01% | 3035 |
|
Other funds holding EPZM
Millennium Management's EPZM Position: Q3 2022 in Review
Millennium Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 1,548,767 shares — an estimated $2.28M sold.
Millennium Management first reported a position in EPZM in Q1 2014 and held it in 31 quarters. The position peaked at $22M in Q1 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Millennium Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Millennium Management sold 1,548,767 Epizyme, Inc shares in Q3 2022, an estimated $2.28M.
- Millennium Management first reported a position in Epizyme, Inc in Q1 2014 and held it in 31 quarters.
- Millennium Management's Epizyme, Inc position peaked at $22M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.